Natural killer cell-activating receptor NKG2D mediates innate immune targeting of allogeneic neural progenitor cell grafts

Stem Cells

Volumn 31, Issue 9, 2013, Pages 1829-1839

  Phillips, Lori K ^a   Gould, Elizabeth A ^b,c   Babu, Harish ^c   Krams, Sheri M ^a,c   Palmer, Theo D ^c   Martinez, Olivia M ^a,c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hippocampus; Lectin like receptor subfamily K; Natural killer cells; Neural stem cells; NKG2D; Stem cell transplantation

Indexed keywords

LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL ACTIVATING LIGAND; NATURAL KILLER CELL RECEPTOR NKG2D; UNCLASSIFIED DRUG;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; INNATE IMMUNITY; MOUSE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION;

HIPPOCAMPUS; LECTIN-LIKE RECEPTOR SUBFAMILY K; NATURAL KILLER CELLS; NEURAL STEM CELLS; NKG2D; STEM CELL TRANSPLANTATION;

ANIMALS; ANTIGENS, LY; CELL MOVEMENT; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNITY, INNATE; KILLER CELLS, NATURAL; LIGANDS; MICE; MICE, INBRED C57BL; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NEURAL STEM CELLS; NEURONS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84885102690     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1422     Document Type: Article

References (54)

1. Lindvall O, Kokaia Z,. Stem cells in human neurodegenerative disorders-Time for clinical translation? J Clin Invest 2010; 120: 29-40.
2. Ormerod BK, Palmer TD, Caldwell MA,. Neurodegeneration and cell replacement. Philos Trans R Soc Lond B Biol Sci 2008; 363: 153-170.
3. Carpentier PA, Palmer TD,. Immune influence on adult neural stem cell regulation and function. Neuron 2009; 64: 79-92.
4. Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe parkinson's disease. New Engl J Med 2001; 344: 710-719.
5. Morizane A, Li JY, Brundin P,. From bench to bed: The potential of stem cells for the treatment of parkinson's disease. Cell Tissue Res 2008; 331: 323-336.
6. Sayles M, Jain M, Barker RA,. The cellular repair of the brain in parkinson's disease-Past, present and future. Transplant Immunol 2004; 12: 321-342.
7. Chen Z, Phillips LK, Gould E, et al. MHC mismatch inhibits neurogenesis and neuron maturation in stem cell allografts. Plos One 2011; 6: e14787.
8. Ideguchi M, Shinoyama M, Gomi M, et al. Immune or inflammatory response by the host brain suppresses neuronal differentiation of transplanted ES cell-derived neural precursor cells. J Neurosci Res 2008; 86: 1936-1943.
9. Mammolenti M, Gajavelli S, Tsoulfas P, et al. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro. Stem Cells 2004; 22: 1101-1110.
10. Odeberg J, Piao JH, Samuelsson EB, et al. Low immunogenicity of in vitro-expanded human neural cells despite high MHC expression. J Neuroimmunol 2005; 161: 1-11.
11. Preynat-Seauve O, de Rham C, Tirefort D, et al. Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells. J Cell Mol Med 2009; 13: 3556-3569.
12. Pearl JI, Lee AS, Leveson-Gower DB, et al. Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells. Cell Stem Cell 2011; 8: 309-317.
13. Boyd AS, Fairchild PJ,. Approaches for immunological tolerance induction to stem cell-derived cell replacement therapies. Expert Rev Clin Immunol 2010; 6: 435-448.
14. Weissman IL, Shizuru JA,. The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood 2008; 112: 3543-3553.
15. Lui KO, Waldmann H, Fairchild PJ,. Embryonic stem cells: Overcoming the immunological barriers to cell replacement therapy. Curr Stem Cell Res Ther 2009; 4: 70-80.
16. Lanier LL,. Nk cell recognition. Annu Rev Immunol 2005; 23: 225-274.
17. Parham P,. MHC class I molecules and KIRS in human history, health and survival. Nat Rev Immunol 2005; 5: 201-214.
18. Pegram HJ, Andrews DM, Smyth MJ, et al. Activating and inhibitory receptors of natural killer cells. Immunol Cell Biol 2011; 89: 216-224.
19. Lin M, Wei LJ, Sellers WR, et al. dChipSNP: Significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics 2004; 20: 1233-1240.
20. Monje ML, Toda H, Palmer TD,. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003; 302: 1760-1765.
21. Lois C, Hong EJ, Pease S, et al. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 2002; 295: 868-872.
22. Matzinger P,. The Jam test. A simple assay for DNA fragmentation and cell death. J Immunol Methods 1991; 145: 185-192.
23. Palmer TD, Willhoite AR, Gage FH,. Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 2000; 425: 479-494.
24. Renault VM, Rafalski VA, Morgan AA, et al. Foxo3 regulates neural stem cell homeostasis. Cell Stem Cell 2009; 5: 527-539.
25. Beckervordersandforth R, Tripathi P, Ninkovic J, et al. In vivo fate mapping and expression analysis reveals molecular hallmarks of prospectively isolated adult neural stem cells. Cell Stem Cell 2010; 7: 744-758.
26. Cedile O, Popa N, Pollet-Villard F, et al. The nkg2d ligands rae-1delta and rae-1epsilon differ with respect to their receptor affinity, expression profiles and transcriptional regulation. PloS one 2010; 5.
27. Carayannopoulos LN, Naidenko OV, Fremont DH, et al. Cutting edge: Murine ul16-binding protein-like transcript 1: A newly described transcript encoding a high-affinity ligand for murine nkg2d. J Immunol 2002; 169: 4079-4083.
28. Diefenbach A, Jamieson AM, Liu SD, et al. Ligands for the murine nkg2d receptor: Expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 2000; 1: 119-126.
29. Karre K,. NK cells, MHC class I molecules and the missing self. Scand J Immunol 2002; 55: 221-228.
30. Hirohashi N, Nakao M, Kubo K, et al. A novel antigen (h47 ag) on human lymphocytes involved in t cell activation. Cell Immunol 1993; 152: 371-382.
31. Ekdahl CT, Claasen JH, Bonde S, et al. Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci USA 2003; 100: 13632-13637.
32. Monje ML, Mizumatsu S, Fike JR, et al. Irradiation induces neural precursor-cell dysfunction. Nat Med 2002; 8: 955-962.
33. Momburg F, Roelse J, Neefjes J, et al. Peptide transporters and antigen processing. Behring Inst Mitt 1994; 94: 26-36.
34. Hori J, Ng TF, Shatos M, et al. Neural progenitor cells lack immunogenicity and resist destruction as allografts. Stem Cells 2003; 21: 405-416.
35. Nomura M, Zou Z, Joh T, et al. Genomic structures and characterization of rae1 family members encoding GPI-anchored cell surface proteins and expressed predominantly in embryonic mouse brain. J Biochem 1996; 120: 987-995.
36. Capetian P, Dobrossy M, Winkler C, et al. To be or not to be accepted: The role of immunogenicity of neural stem cells following transplantation into the brain in animal and human studies. Semin Immunopathol 2011; 33: 619-626.
37. Chen Z, Palmer TD,. Cellular repair of CNS disorders: An immunological perspective. Hum Mol Genet 2008; 17: R84-92.
38. Bailey SL, Carpentier PA, McMahon EJ, et al. Innate and adaptive immune responses of the central nervous system. Crit Rev Immunol 2006; 26: 149-188.
39. Bonde S, Zavazava N,. Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients. Stem Cells 2006; 24: 2192-2201.
40. Koch CA, Geraldes P, Platt JL,. Immunosuppression by embryonic stem cells. Stem Cells 2008; 26: 89-98.
41. Drukker M, Katz G, Urbach A, et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 2002; 99: 9864-9869.
42. Dressel R, Nolte J, Elsner L, et al. Pluripotent stem cells are highly susceptible targets for syngeneic, allogeneic, and xenogeneic natural killer cells. FASEB J 2010; 24: 2164-2177.
43. Nguyen HN, Byers B, Cord B, et al. Lrrk2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 2011; 8: 267-280.
44. Chen LW, Kuang F, Wei LC, et al. Potential application of induced pluripotent stem cells in cell replacement therapy for parkinson's disease. CNS Neurol Disord Drug Targets 2011; 10: 449-458.
45. Zou Z, Nomura M, Takihara Y, et al. Isolation and characterization of retinoic acid-inducible cdna clones in f9 cells: A novel CDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules. J Biochem 1996; 119: 319-328.
46. Popa N, Cedile O, Pollet-Villard X, et al. Rae-1 is expressed in the adult subventricular zone and controls cell proliferation of neurospheres. Glia 2011; 59: 35-44.
47. Kim J, Chang CK, Hayden T, et al. The activating immunoreceptor nkg2d and its ligands are involved in allograft transplant rejection. J Immunol 2007; 179: 6416-6420.
48. Gasser S, Orsulic S, Brown EJ, et al. The DNA damage pathway regulates innate immune system ligands of the nkg2d receptor. Nature 2005; 436: 1186-1190.
49. Covacu R, Arvidsson L, Andersson A, et al. TLR activation induces TNF-alpha production from adult neural stem/progenitor cells. J Immunol 2009; 182: 6889-6895.
50. Yaddanapudi K, De Miranda J, Hornig M, et al. Toll-like receptor 3 regulates neural stem cell proliferation by modulating the sonic hedgehog pathway. Plos One 2011; 6: 25.
51. Wilson EH, Weninger W, Hunter CA,. Trafficking of immune cells in the central nervous system. J Clin Invest 2010; 120: 1368-1379.
52. Ho EL, Carayannopoulos LN, Poursine-Laurent J, et al. Costimulation of multiple nk cell activation receptors by nkg2d. J Immunol 2002; 169: 3667-3675.
53. Nedellec S, Sabourin C, Bonneville M, et al. Nkg2d costimulates human v gamma 9v delta 2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCR-induced calcium and transduction signals. J Immunol 2010; 185: 55-63.
54. Kuylenstierna C, Bjorkstrom NK, Andersson SK, et al. Nkg2d performs two functions in invariant NKT cells: Direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by cd1d. Eur J Immunol 2011; 41: 1913-1923.